Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCHW) Gross Margin (2022 - 2025)

Historic Gross Margin for Envoy Medical (COCHW) over the last 4 years, with Q3 2025 value amounting to 864.29%.

  • Envoy Medical's Gross Margin fell 2607100.0% to 864.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 689.42%, marking a year-over-year decrease of 1674800.0%. This contributed to the annual value of 670.67% for FY2024, which is 2434500.0% down from last year.
  • According to the latest figures from Q3 2025, Envoy Medical's Gross Margin is 864.29%, which was down 2607100.0% from 362.82% recorded in Q2 2025.
  • In the past 5 years, Envoy Medical's Gross Margin registered a high of 85.96% during Q3 2022, and its lowest value of 2590.0% during Q4 2022.
  • Its 4-year average for Gross Margin is 701.71%, with a median of 507.94% in 2023.
  • As far as peak fluctuations go, Envoy Medical's Gross Margin skyrocketed by 21500000bps in 2023, and later tumbled by -6933300bps in 2024.
  • Over the past 4 years, Envoy Medical's Gross Margin (Quarter) stood at 2590.0% in 2022, then surged by 83bps to 440.0% in 2023, then crashed by -158bps to 1133.33% in 2024, then grew by 24bps to 864.29% in 2025.
  • Its Gross Margin stands at 864.29% for Q3 2025, versus 362.82% for Q2 2025 and 678.26% for Q1 2025.